JAZZ•benzinga•
Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study
Summary
Jazz Pharma's Zepzelca plus Tecentriq significantly improved survival in a Phase 3 study for extensive-stage small-cell lung cancer patients.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 3, 2025 by benzinga